| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.61 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |